Minerva Neurosciences, Inc. (NERV) Sof foyda bo'yicha sotuv rentabelligi

Minerva Neurosciences Corp - NERV emitenti grafik logotipi

Minerva Neurosciences (NERV) tartibga soluvchi o'zgarishlar xavfini kamaytirish uchun markaziy nerv tizimi buzilishlarini davolashga mo'ljallangan kichik molekulalarning diversifikatsiyalashgan portfelini ishlab chiqmoqda. GURU.Markets grafigida vaqtlar ketma-ketligi sifatida taqdim etilgan kompaniyaning sof foyda marjasi ushbu trayektoriya ko'rinishini vizuallashtiradi, bunda 0.00 yangi darajani belgilaydi. Roluperidonni ishlab chiqish shizofreniyadagi ijtimoiy rehabilitatsiya muammolarini hal qilishga qaratilgan bo'lsa-da, sotuvlarning yo'qligi naqd pul zaxiralarining barqaror kamayishiga olib kelmoqda.

Minerva Neurosciences (NERV) Sof foyda normasi: 04.07.2022 - 19.11.2026 davri uchun

Minerva Neurosciences Corp (NERV) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning asosiy tahlili:Minerva Neurosciences Inc - NERV
Minerva Neurosciences Inc ishlab chiqargan mahsulot

Sof foyda marjasi sof daromadning umumiy tushumga nisbati sifatida hisoblanadi. Ushbu ko'rsatkich barcha xarajatlar chegirib tashlanganidan keyin, biznes topilgan har bir dollardan qancha foydani saqlab qolishini belgilaydi. Minerva Neurosciences (NERV) uchun ushbu raqam dori vositalarini ishlab chiqishda avtomatlashtirilgan bioinformatika platformalarini joriy etish samaradorligini aks ettiradi. Laboratoriya jarayonlarining optimallashtirilishi operatsion rentabellikka bevosita ta'sir ko'rsatadi. Sof foyda marjasidagi tendentsiya kompaniyaning moliyaviy barqarorligini real vaqt rejimida baholash imkonini beradi.

Minerva Neurosciences (NERV) raqobatchilari

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|ATHA: Sof foyda normasi|Sof marja Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi CYCN (cyclerion.com)|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel